Prevalence of iodine- and thyroglobulin-negative findings in differentiated thyroid cancer: A retrospective analysis of patients treated from 1961 to 1998 in a University Hospital;Häufigkeit lod- und hTG-negativer befunde beim differenzierten schilddrüsenkarzinom: Eine retrospektive analyse der von 1961 bis 1998 in einer Universitätsklinik behandelten patienten

NuklearMedizin

Volumn 40, Issue 5, 2001, Pages 143-147

  Klutmann, S ^a   Jenicke, L ^a   Geiss Tonshoff M ^a   Bohuslavizki, K H ^a   Mester, J ^a   Clausen, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Iodine scan; Metastases; Recurrence; Thyroglobulin; Thyroid cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THYROGLOBULIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FOLLICULAR CARCINOMA; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; RADIODIAGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THYROID CARCINOMA;

EID: 0035177187     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623879     Document Type: Article

References (16)

1. 131J-speichernde pulmonale und ossäre metastasen differenzierter schilddrüsenkarzinome bei niedrigem serum-thyreoglobulinspiegel-ausnahme in der tumornachsorge
2. Thyreoglobulin, 131J-ganzkörperszintigraphie und risikofaktoren in der nachsorge des differenzierten schilddrüsenkarzinoms
3. 99mTc-MIBI in the follow up of thyroid cancer
4. Increased sensitivity of whole-body scintigraphy with 131I for the detection of iodine-accumulating metastases by means of delayed imaging
5. Procedures for iodine-131 whole body scintigraphy in the differential diagnosis of thyroid cancer
6. Follow-up of differentiated thyroid cancer: What is the value of FDG and sestamibi in the diagnostic algorithm?
7. Thyroblobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma
8. Survival of differentiated thyroid carcinoma studied in 500 patients
9. Der röntgenthorax: Routineindikation in der nachsorge des differenzierten schilddrüsenkarzinoms?
10. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma
11. Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer
12. Serum-thyreoglobulin in der metastasendiagnostik des differenzierten schilddrüsenkarzinoms
13. Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values
14. Evaluation and treatment of persistent thyroglobulinemia in patients with well-differentiated thyroid cancer
15. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroblobulin levels
16. Thallium-201 scintigraphy in differentiated thyroid cancer. Comparison with radioiodine scintigraphy and serum thyroglobulin determinations